World's 2nd Richest Man Is About To Shock The World
Elon Musk changed online payment processing with Paypal. He's changing space exploration with SpaceX and the auto industry with Tesla.

And now, Elon Musk is getting ready to unveil his next big project: S.A.V. It's so revolutionary; it could even put an extra $30,000 in Americans' pockets.
See what was caught on camera

AMRX Insider Trading (Amneal Pharmaceuticals)

Insider Ownership Percentage: 26.32%
Insider Buying (Last 12 Months): $1,581,489.91
Insider Selling (Last 12 Months): $0.00

Amneal Pharmaceuticals Insider Trading History Chart

Amneal Pharmaceuticals Share Price & Price History

▲ +0.69 (13.94%)
As of 03/8/2021 04:57 PM ET
Days: 30 | 90 | 365
The Best High Growth Cannabis Stock for 2021
An undiscovered Canadian company could be the next cannabis industry player to explode in Canada. With a unique strategy this company could be about to dominate the space and is trading under $1!
Continue Reading

Amneal Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/19/2020John KielyDirectorBuy10,000$4.53$45,300.00
5/15/2020Jeffrey P GeorgeDirectorBuy23,810$4.16$99,049.6023,810  
3/18/2020Paul M MeisterDirectorBuy353,649$3.19$1,128,140.31149,439  
3/10/2020Chintu PatelCEOBuy100,000$3.09$309,000.00356,107  
3/4/2020Chirag K PatelCEOBuy58,938$3.97$233,983.8640,748  
3/2/2020Chirag K PatelCEOBuy34,641$3.87$134,060.6740,748  
3/2/2020Gautam PatelDirectorBuy32,111$3.88$124,590.6838,218  
2/28/2020Joseph TodiscoSVPBuy40,000$3.62$144,800.00246,845  
8/28/2019Ted C NarkDirectorBuy50,000$2.39$119,500.00  
8/16/2019Pradeep BhadauriaSVPBuy30,000$2.41$72,300.00  
8/7/2019Andrew S BoyerVPBuy66,666$2.89$192,664.74  
8/5/2019International Ltd FosunMajor ShareholderBuy1,642,300$3.04$4,992,592.00  
5/15/2019Pradeep BhadauriaSVPBuy7,000$8.48$59,360.00  
5/13/2019Andrew S BoyerVPBuy19,000$9.46$179,740.00  
5/13/2019Joseph TodiscoSVPBuy15,000$9.88$148,200.00  
3/12/2019Paul BisaroInsiderBuy17,000$11.97$203,490.00  
3/6/2019Peter R TerreriDirectorSell23,345$12.39$289,244.55  
8/21/2018Bryan M ReasonsCFOSell11,698$23.65$276,657.70  
8/21/2018Nikita ShahSVPSell50,000$23.46$1,173,000.00  
See Full Table

SEC Filings (Institutional Ownership Changes) for Amneal Pharmaceuticals (NYSE:AMRX)

33.49% of Amneal Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Amneal Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
3/8/2021Dimensional Fund Advisors LP448,648$2.05M0.0%+51.7%0.150%
3/2/2021Norges Bank1,093,954$5M0.0%N/A0.365%
3/1/2021UBS Asset Management Americas Inc.89,605$0.41M0.0%-21.8%0.030%
2/25/2021Dimensional Fund Advisors LP448,648$2.05M0.0%+51.7%0.150%
2/25/2021Tranquilli Financial Advisor LLC71,414$0.33M0.3%N/A0.024%
2/23/2021Principal Financial Group Inc.132,619$0.61M0.0%-23.0%0.044%
2/19/2021JPMorgan Chase & Co.487,672$2.23M0.0%+1,219.0%0.163%
2/17/2021Jane Street Group LLC29,285$0.13M0.0%N/A0.010%
2/16/2021Zacks Investment Management15,835$72K0.0%-87.2%0.005%
2/16/2021Squarepoint Ops LLC93,034$0.43M0.0%-43.2%0.031%
2/16/2021Nuveen Asset Management LLC575,557$2.63M0.0%+43.5%0.192%
2/16/2021Virginia Retirement Systems ET AL40,300$0.18M0.0%+276.6%0.013%
2/16/2021Engineers Gate Manager LP135,143$0.62M0.0%+18.9%0.045%
2/16/2021Prelude Capital Management LLC338,426$1.55M0.0%+23.5%0.113%
2/12/2021CWM Advisors LLC46,314$0.21M0.0%+51.5%0.015%
2/12/2021LPL Financial LLC23,635$0.11M0.0%+40.2%0.008%
2/12/2021Credit Suisse AG109,266$0.50M0.0%+67.4%0.036%
2/12/2021Magnetar Financial LLC551,792$2.52M0.0%N/A0.184%
2/11/2021Lazard Asset Management LLC7,290$33K0.0%N/A0.002%
2/11/2021Barrow Hanley Mewhinney & Strauss LLC19,235$88K0.0%-11.7%0.006%
2/11/2021Globeflex Capital L P165,598$0.76M0.2%-34.2%0.055%
2/11/2021Northern Trust Corp1,396,461$6.38M0.0%-3.7%0.466%
2/11/2021Barclays PLC106,119$0.49M0.0%-18.8%0.035%
2/11/2021Citigroup Inc.28,319$0.13M0.0%-18.0%0.009%
2/11/2021Dynamic Technology Lab Private Ltd15,244$70K0.0%N/A0.005%
2/10/2021Rhumbline Advisers161,043$0.74M0.0%+4.7%0.054%
2/10/2021Renaissance Technologies LLC172,549$0.79M0.0%N/A0.058%
2/10/2021Brandywine Global Investment Management LLC185,188$0.85M0.0%N/A0.062%
2/9/2021Smith Asset Management Group LP72,630$0.33M0.0%-58.2%0.024%
2/9/2021Wells Fargo & Company MN336,431$1.54M0.0%-9.6%0.112%
2/9/2021Bank of New York Mellon Corp774,820$3.54M0.0%-22.4%0.258%
2/9/2021ProShare Advisors LLC21,972$100K0.0%+80.8%0.007%
2/8/2021Alliancebernstein L.P.177,049$0.81M0.0%-5.6%0.059%
2/8/2021Russell Investments Group Ltd.168,334$0.77M0.0%+119.2%0.056%
2/5/2021BlackRock Inc.7,406,795$33.85M0.0%-11.0%2.471%
2/5/2021Aperio Group LLC89,637$0.41M0.0%+9.4%0.030%
2/5/2021THB Asset Management1,014,495$4.64M1.1%+21.8%0.338%
2/5/2021SG Americas Securities LLC18,876$86K0.0%N/A0.006%
2/5/2021CM Management LLC125,000$0.57M0.5%N/A0.042%
2/4/2021GSA Capital Partners LLP39,552$0.18M0.0%-26.6%0.013%
2/4/2021State of Wisconsin Investment Board211,100$0.97M0.0%-20.8%0.070%
2/1/2021Victory Capital Management Inc.171,239$0.78M0.0%+75.4%0.057%
2/1/2021Hussman Strategic Advisors Inc.123,000$0.56M0.1%+20.6%0.041%
2/1/2021Assenagon Asset Management S.A.247,725$1.13M0.0%+1,231.9%0.083%
1/25/2021Strs Ohio153,400$0.70M0.0%+6.5%0.051%
1/13/2021Iron Financial LLC10,000$46K0.0%N/A0.003%
12/14/2020Strs Ohio144,100$0.56M0.0%+24.8%0.048%
11/17/2020Paloma Partners Management Co42,039$0.16M0.0%-54.2%0.014%
11/16/2020Point72 Hong Kong Ltd6,961$27K0.0%N/A0.002%
11/16/2020Cubist Systematic Strategies LLC97,894$0.38M0.0%-23.4%0.033%
11/16/2020Squarepoint Ops LLC163,757$0.64M0.0%+1,296.1%0.055%
11/16/2020Peapack Gladstone Financial Corp25,002$97K0.0%N/A0.008%
11/13/2020Morgan Stanley251,038$0.97M0.0%+187.9%0.084%
11/13/2020Charles Schwab Investment Management Inc.728,101$2.83M0.0%-3.6%0.243%
11/13/2020Globeflex Capital L P251,696$0.98M0.3%+4.6%0.084%
11/12/2020Connor Clark & Lunn Investment Management Ltd.18,014$70K0.0%-94.0%0.006%
11/12/2020JPMorgan Chase & Co.36,973$0.14M0.0%+10.1%0.012%
11/12/2020Arrowstreet Capital Limited Partnership114,213$0.44M0.0%-91.1%0.038%
11/12/2020Neuberger Berman Group LLC3,685,477$14.28M0.0%-1.4%1.230%
11/12/2020Federated Hermes Inc.123,281$0.48M0.0%+9.0%0.041%
11/10/2020State Street Corp2,493,033$9.67M0.0%-10.2%0.832%
11/9/2020Victory Capital Management Inc.97,637$0.38M0.0%+108.5%0.033%
11/9/2020LPL Financial LLC16,860$65K0.0%N/A0.006%
11/6/2020BlackRock Inc.8,325,485$32.30M0.0%-4.2%2.778%
11/6/2020Aperio Group LLC81,940$0.32M0.0%-4.1%0.027%
11/6/2020GSA Capital Partners LLP53,864$0.21M0.0%+7.9%0.018%
11/5/2020California Public Employees Retirement System274,007$1.06M0.0%+7.2%0.091%
11/5/2020Wells Fargo & Company MN372,123$1.45M0.0%+20.4%0.124%
11/4/2020Raymond James & Associates174,229$0.68M0.0%+3.9%0.058%
11/4/2020Mackay Shields LLC233,100$0.90M0.0%N/A0.078%
11/2/2020Hussman Strategic Advisors Inc.102,000$0.40M0.1%N/A0.034%
11/2/2020Meeder Asset Management Inc.11,960$47K0.0%-47.3%0.004%
10/30/2020BNP Paribas Arbitrage SA53,824$0.21M0.0%-75.6%0.018%
10/30/2020Banque Cantonale Vaudoise9,000$35K0.0%N/A0.003%
10/30/2020WINTON GROUP Ltd32,070$0.12M0.0%N/A0.011%
10/29/2020XTX Markets LLC10,243$40K0.2%N/A0.003%
10/23/2020LSV Asset Management1,113,300$4.32M0.0%+19.0%0.372%
10/22/2020NEXT Financial Group Inc6,800$26K0.0%-38.7%0.002%
10/9/2020Envestnet Asset Management Inc.11,271$44K0.0%N/A0.004%
10/7/2020Assenagon Asset Management S.A.18,600$72K0.0%-97.1%0.006%
9/15/2020Two Sigma Advisers LP237,349$1.13M0.0%-23.5%0.079%
9/4/2020Principal Financial Group Inc.113,591$0.54M0.0%+21.0%0.038%
8/31/2020Bridgeway Capital Management Inc.245,500$1.17M0.0%N/A0.082%
8/27/2020Neuberger Berman Group LLC3,739,184$17.79M0.0%-2.4%1.248%
8/26/2020Quadrature Capital Ltd88,300$0.42M0.0%+589.8%0.029%
8/26/2020Handelsbanken Fonder AB18,874$90K0.0%N/A0.006%
8/25/2020Nuveen Asset Management LLC510,976$2.43M0.0%-6.0%0.171%
8/20/2020Charles Schwab Investment Management Inc.755,016$3.59M0.0%+6.8%0.252%
8/17/2020Engineers Gate Manager LP229,377$1.09M0.1%+79.8%0.077%
8/17/2020California State Teachers Retirement System149,539$0.71M0.0%-16.8%0.050%
8/17/2020Jacobs Levy Equity Management Inc.70,049$0.33M0.0%-71.7%0.023%
8/14/2020Cubist Systematic Strategies LLC127,778$0.61M0.0%+516.3%0.043%
8/14/2020Bank of America Corp DE410,239$1.95M0.0%-18.0%0.137%
8/14/2020Vanguard Group Inc.11,234,972$53.48M0.0%+4.6%3.752%
8/14/2020Advisor Group Holdings Inc.48,082$0.23M0.0%+13.4%0.016%
8/13/2020Federated Hermes Inc.113,082$0.54M0.0%-92.3%0.038%
8/12/2020Bank of Montreal Can14,490$64K0.0%+271.3%0.005%
8/12/2020CWM Advisors LLC40,858$0.19M0.1%-30.2%0.014%
8/12/2020American International Group Inc.60,656$0.29M0.0%-13.3%0.020%
8/12/2020Goldman Sachs Group Inc.165,393$0.79M0.0%-67.9%0.055%
Data available starting January 2016

See Full Table
Amneal Pharmaceuticals logo
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates in two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers licensed and owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinsons Disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; and Unithroid for the treatment of hypothyroidism. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It has operations in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is based in Bridgewater, New Jersey.
Read More

Today's Range

Now: $5.64

50 Day Range

MA: $5.19

52 Week Range

Now: $5.64


310,551 shs

Average Volume

1,728,760 shs

Market Capitalization

$1.69 billion

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Amneal Pharmaceuticals?

Amneal Pharmaceuticals' top insider investors include:
  1. Chintu Patel (CEO)
  2. Joseph Todisco (SVP)
  3. Paul M Meister (Director)
  4. Chirag K Patel (CEO)
  5. Gautam Patel (Director)
  6. Jeffrey P George (Director)
  7. Andrew S Boyer (VP)
  8. International Ltd Fosun (Major Shareholder)
  9. John Kiely (Director)
  10. Paul Bisaro (Insider)
  11. Pradeep Bhadauria (SVP)
  12. Ted C Nark (Director)

Who are the major institutional investors of Amneal Pharmaceuticals?

Amneal Pharmaceuticals' top institutional shareholders include:
  1. BlackRock Inc. — 2.47%
  2. Northern Trust Corp — 0.47%
  3. Norges Bank — 0.36%
  4. THB Asset Management — 0.34%
  5. Bank of New York Mellon Corp — 0.26%
  6. Nuveen Asset Management LLC — 0.19%

Which institutional investors are selling Amneal Pharmaceuticals stock?

During the previous quarter, AMRX stock was sold by these institutional investors:
  1. BlackRock Inc.
  2. Bank of New York Mellon Corp
  3. Zacks Investment Management
  4. Smith Asset Management Group LP
  5. Globeflex Capital L P
  6. Squarepoint Ops LLC
  7. State of Wisconsin Investment Board
  8. Northern Trust Corp

Which institutional investors are buying Amneal Pharmaceuticals stock?

Within the previous quarter, AMRX stock was purchased by institutional investors including:
  1. Norges Bank
  2. Magnetar Financial LLC
  3. JPMorgan Chase & Co.
  4. Assenagon Asset Management S.A.
  5. Brandywine Global Investment Management LLC
  6. THB Asset Management
  7. Nuveen Asset Management LLC
  8. Renaissance Technologies LLC
In the previous year, these company insiders have bought Amneal Pharmaceuticals stock:
  1. Chintu Patel (CEO)
  2. Joseph Todisco (SVP)
  3. Paul M Meister (Director)
  4. Chirag K Patel (CEO)
  5. Gautam Patel (Director)
  6. Jeffrey P George (Director)
  7. Andrew S Boyer (VP)
  8. International Ltd Fosun (Major Shareholder)
  9. John Kiely (Director)
  10. Paul Bisaro (Insider)
  11. Pradeep Bhadauria (SVP)
  12. Ted C Nark (Director)
Thinking of buying options? DON’T- Read this first
Options traders place high-risk trades, hoping for a big payout. But they lose... a LOT! That's why Jim Fink flips options trading on its head, making money over 85% of the time. His personal strategy guide could help you unlock as much as $67,548 in extra income.
Click here for the dirty details.